Macrolide statin interaction — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Increased statin exposure and myopathy risk
Clarithromycin inhibits CYP3A4 and can increase simvastatin concentrations. The interaction should be managed by withholding or changing therapy according to prescriber advice. In this scenario, the correct option is increased statin exposure and myopathy risk. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.
Reference: BNF; Stockley's Drug Interactions